GSTM1 and anemia: The primary objective of the Comprehensive Anaemia Programme and Personalized Therapies (CAPPT) trial is to assess the impact on haemoglobin (Hb) at 30 ± 2 weeks of pregnancy, of an integrated intervention providing personalised nutrition counselling at pregnant women’s homes, together with tailored dosage of oral iron-folic acid (IFA) and PLA women’s groups in the community, in addition to routine ANC, compared with a control arm where women have access to routine ANC only.